393 related articles for article (PubMed ID: 21135115)
21. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
[TBL] [Abstract][Full Text] [Related]
22. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft.
Fu J; Rodova M; Roy SK; Sharma J; Singh KP; Srivastava RK; Shankar S
Cancer Lett; 2013 Mar; 330(1):22-32. PubMed ID: 23200667
[TBL] [Abstract][Full Text] [Related]
23. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
Arnhold V; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
[TBL] [Abstract][Full Text] [Related]
24. Hedgehog Signal Inhibitor GANT61 Inhibits the Malignant Behavior of Undifferentiated Hepatocellular Carcinoma Cells by Targeting Non-Canonical GLI Signaling.
Harada K; Ohashi R; Naito K; Kanki K
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354204
[TBL] [Abstract][Full Text] [Related]
25. The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer.
Zhang H; Hu L; Cheng M; Wang Q; Hu X; Chen Q
Oncol Rep; 2020 Dec; 44(6):2610-2620. PubMed ID: 33125122
[TBL] [Abstract][Full Text] [Related]
26. Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing.
Zhang R; Wu J; Ferrandon S; Glowacki KJ; Houghton JA
Oncotarget; 2016 Dec; 7(49):80190-80207. PubMed ID: 27863397
[TBL] [Abstract][Full Text] [Related]
27. LKB1 inhibits breast cancer partially through repressing the Hedgehog signaling pathway.
Zhuang Z; Wang K; Cheng X; Qu X; Jiang B; Li Z; Luo J; Shao Z; Duan T
PLoS One; 2013; 8(7):e67431. PubMed ID: 23861764
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells.
Desch P; Asslaber D; Kern D; Schnidar H; Mangelberger D; Alinger B; Stoecher M; Hofbauer SW; Neureiter D; Tinhofer I; Aberger F; Hartmann TN; Greil R
Oncogene; 2010 Sep; 29(35):4885-95. PubMed ID: 20603613
[TBL] [Abstract][Full Text] [Related]
29. Non-canonical GLI1/2 activation by PI3K/AKT signaling in renal cell carcinoma: A novel potential therapeutic target.
Zhou J; Zhu G; Huang J; Li L; Du Y; Gao Y; Wu D; Wang X; Hsieh JT; He D; Wu K
Cancer Lett; 2016 Jan; 370(2):313-23. PubMed ID: 26577809
[TBL] [Abstract][Full Text] [Related]
30. Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms.
Singh BN; Fu J; Srivastava RK; Shankar S
PLoS One; 2011; 6(11):e27306. PubMed ID: 22087285
[TBL] [Abstract][Full Text] [Related]
31. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
32. GPR126 regulates colorectal cancer cell proliferation by mediating HDAC2 and GLI2 expression.
Cui H; Yu W; Yu M; Luo Y; Yang M; Cong R; Chu X; Gao G; Zhong M
Cancer Sci; 2021 May; 112(5):1798-1810. PubMed ID: 33629464
[TBL] [Abstract][Full Text] [Related]
33. GLI3-dependent transcriptional repression of Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis.
Hu MC; Mo R; Bhella S; Wilson CW; Chuang PT; Hui CC; Rosenblum ND
Development; 2006 Feb; 133(3):569-78. PubMed ID: 16396903
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
[TBL] [Abstract][Full Text] [Related]
35. Expression of sonic hedgehog signaling molecules in normal, hyperplastic and carcinomatous endometrium.
Kim KH; Kim JM; Choi YL; Shin YK; Lee HC; Seong IO; Kim BK; Chae SW; Chung YS; Kim SH
Pathol Int; 2009 May; 59(5):279-87. PubMed ID: 19432668
[TBL] [Abstract][Full Text] [Related]
36. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma.
Yan M; Wang L; Zuo H; Zhang Z; Chen W; Mao L; Zhang P
Oral Oncol; 2011 Jun; 47(6):504-9. PubMed ID: 21536478
[TBL] [Abstract][Full Text] [Related]
37. Concomitant targeting of Hedgehog signaling and MCL-1 synergistically induces cell death in Hedgehog-driven cancer cells.
Meister MT; Boedicker C; Linder B; Kögel D; Klingebiel T; Fulda S
Cancer Lett; 2019 Nov; 465():1-11. PubMed ID: 31465840
[TBL] [Abstract][Full Text] [Related]
38. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells.
Wang Y; Han C; Lu L; Magliato S; Wu T
Hepatology; 2013 Sep; 58(3):995-1010. PubMed ID: 23504944
[TBL] [Abstract][Full Text] [Related]
39. Targeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells.
Faião-Flores F; Alves-Fernandes DK; Pennacchi PC; Sandri S; Vicente AL; Scapulatempo-Neto C; Vazquez VL; Reis RM; Chauhan J; Goding CR; Smalley KS; Maria-Engler SS
Oncogene; 2017 Mar; 36(13):1849-1861. PubMed ID: 27748762
[TBL] [Abstract][Full Text] [Related]
40. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma.
Lo WW; Wunder JS; Dickson BC; Campbell V; McGovern K; Alman BA; Andrulis IL
Cancer; 2014 Feb; 120(4):537-47. PubMed ID: 24151134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
